Hanny Fredrix

1.2k total citations
24 papers, 976 citations indexed

About

Hanny Fredrix is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Hanny Fredrix has authored 24 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 11 papers in Hematology and 9 papers in Oncology. Recurrent topics in Hanny Fredrix's work include Immunotherapy and Immune Responses (17 papers), T-cell and B-cell Immunology (11 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Hanny Fredrix is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), T-cell and B-cell Immunology (11 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Hanny Fredrix collaborates with scholars based in Netherlands, United States and Belgium. Hanny Fredrix's co-authors include Harry Dolstra, Nicolaas Schaap, Willemijn Hobo, E. van de Wiel-van Kemenade, Theo M. de Witte, Frans Maas, Robbert van der Voort, Carl G. Figdor, J.H. Frederik Falkenburg and Pierre G. Coulie and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Hanny Fredrix

24 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanny Fredrix Netherlands 18 798 416 290 254 69 24 976
Janelle A. Olson United States 6 753 0.9× 406 1.0× 272 0.9× 96 0.4× 67 1.0× 14 883
Gong Yun United States 6 1.5k 1.8× 978 2.4× 516 1.8× 181 0.7× 92 1.3× 7 1.7k
Yvette Soignier United States 3 1.3k 1.7× 930 2.2× 483 1.7× 118 0.5× 87 1.3× 6 1.5k
Jooeun Bae United States 17 578 0.7× 453 1.1× 472 1.6× 513 2.0× 25 0.4× 37 1.1k
Susan K. Fautsch United States 8 1.5k 1.8× 1.0k 2.5× 624 2.2× 130 0.5× 100 1.4× 9 1.7k
Brea A. Jewell United States 6 871 1.1× 541 1.3× 164 0.6× 135 0.5× 47 0.7× 7 991
Zhiqing Wang United States 16 586 0.7× 158 0.4× 94 0.3× 418 1.6× 110 1.6× 28 820
Sara Abdel-Latif United States 3 821 1.0× 527 1.3× 159 0.5× 102 0.4× 44 0.6× 4 919
Cecilia Barese United States 13 381 0.5× 383 0.9× 68 0.2× 178 0.7× 149 2.2× 25 674
Liyang Yu China 5 592 0.7× 417 1.0× 126 0.4× 107 0.4× 44 0.6× 7 708

Countries citing papers authored by Hanny Fredrix

Since Specialization
Citations

This map shows the geographic impact of Hanny Fredrix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanny Fredrix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanny Fredrix more than expected).

Fields of papers citing papers by Hanny Fredrix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanny Fredrix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanny Fredrix. The network helps show where Hanny Fredrix may publish in the future.

Co-authorship network of co-authors of Hanny Fredrix

This figure shows the co-authorship network connecting the top 25 collaborators of Hanny Fredrix. A scholar is included among the top collaborators of Hanny Fredrix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanny Fredrix. Hanny Fredrix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evert, Janneke S. Hoogstad‐van, Paul K.J.D. de Jonge, Petra L.M. Zusterzeel, et al.. (2025). Intraperitoneal infusion of stem cell-derived natural killer cells in recurrent epithelial ovarian cancer patients: Results of the phase 1 INTRO-01 trial. Gynecologic Oncology. 204. 91–99. 1 indexed citations
2.
Waart, Anniek B. van der, Diana Campillo-Davó, Hanny Fredrix, et al.. (2020). PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity. Bone Marrow Transplantation. 55(12). 2308–2318. 15 indexed citations
3.
Hobo, Willemijn, Yun Ji, Hanny Fredrix, et al.. (2018). Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy. OncoImmunology. 7(10). e1488565–e1488565. 45 indexed citations
4.
Roeven, Mieke W.H., Willemijn Hobo, Remco van Doorn, et al.. (2017). A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma. Bone Marrow Transplantation. 52(10). 1378–1383. 23 indexed citations
5.
Thordardottir, Soley, Hanny Fredrix, Rob Woestenenk, et al.. (2016). CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses. The Journal of Immunology. 197(7). 2715–2725. 40 indexed citations
6.
Waart, Anniek B. van der, Hanny Fredrix, Robbert van der Voort, et al.. (2015). siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8+ T cells in NOD/SCID/IL2Rg(null) mice. Cancer Immunology Immunotherapy. 64(5). 645–654. 41 indexed citations
7.
Roeven, Mieke W.H., Willemijn Hobo, Robbert van der Voort, et al.. (2015). Efficient Nontoxic Delivery of PD-L1 and PD-L2 siRNA Into Dendritic Cell Vaccines Using the Cationic Lipid SAINT-18. Journal of Immunotherapy. 38(4). 145–154. 40 indexed citations
8.
Hobo, Willemijn, Frans Maas, Hanny Fredrix, et al.. (2013). Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients. Cancer Immunology Immunotherapy. 62(8). 1381–1392. 61 indexed citations
9.
Hobo, Willemijn, Tatiana I. Novobrantseva, Hanny Fredrix, et al.. (2012). Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation. Cancer Immunology Immunotherapy. 62(2). 285–297. 113 indexed citations
10.
Broen, Kelly, et al.. (2012). Induction of multiple myeloma-reactive T cells during post-transplantation immunotherapy with donor lymphocytes and recipient DCs. Bone Marrow Transplantation. 47(9). 1229–1234. 5 indexed citations
11.
Hobo, Willemijn, Kelly Broen, Walter J. F. M. van der Velden, et al.. (2012). Association of Disparities in Known Minor Histocompatibility Antigens with Relapse-Free Survival and Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 19(2). 274–282. 37 indexed citations
12.
Broen, Kelly, Cornelis A.M. van Bergen, Hanny Fredrix, et al.. (2011). A Polymorphism in the Splice Donor Site of ZNF419 Results in the Novel Renal Cell Carcinoma-Associated Minor Histocompatibility Antigen ZAPHIR. PLoS ONE. 6(6). e21699–e21699. 22 indexed citations
13.
Fredrix, Hanny, Michel G.D. Kester, J.H. Frederik Falkenburg, et al.. (2009). Efficient Activation of LRH-1–specific CD8+ T-cell Responses From Transplanted Leukemia Patients by Stimulation With P2X5 mRNA-electroporated Dendritic Cells. Journal of Immunotherapy. 32(6). 539–551. 12 indexed citations
14.
Fredrix, Hanny, Aniek O. de Graaf, Joop H. Jansen, et al.. (2008). Expression of P2X5 in lymphoid malignancies results in LRH‐1‐specific cytotoxic T‐cell‐mediated lysis. British Journal of Haematology. 141(6). 799–807. 33 indexed citations
15.
Veenbergen, Sharon, et al.. (2007). Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigens. Journal of Immunological Methods. 329(1-2). 125–137. 1 indexed citations
16.
Dolstra, Harry, Hanny Fredrix, A. Balas, et al.. (2002). Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes. European Journal of Immunology. 32(10). 2748–2758. 45 indexed citations
17.
Dolstra, Harry, Hanny Fredrix, A. van der Meer, et al.. (2001). TCRγδ cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells. Bone Marrow Transplantation. 27(10). 1087–1093. 44 indexed citations
18.
Dolstra, Harry, Hanny Fredrix, Frans Maas, et al.. (1999). A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia. The Journal of Experimental Medicine. 189(2). 301–308. 180 indexed citations
19.
Dolstra, Harry, Hanny Fredrix, Els Goulmy, et al.. (1997). Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL. The Journal of Immunology. 158(2). 560–565. 76 indexed citations
20.
Hermsen, Cornelus C., et al.. (1997). Circulating Tumour Necrosis Factor α is not involved in the development of cerebral malaria in Plasmodium berghei‐infected C57Bl mice. Parasite Immunology. 19(12). 571–577. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026